TY - JOUR
T1 - Non-Surgical Interventions for Lumbar Spinal Stenosis Leading To Neurogenic Claudication
T2 - A Clinical Practice Guideline
AU - Bussières, André
AU - Cancelliere, Carolina
AU - Ammendolia, Carlo
AU - Comer, Christine M.
AU - Zoubi, Fadi Al
AU - Châtillon, Claude Edouard
AU - Chernish, Greg
AU - Cox, James M.
AU - Gliedt, Jordan A.
AU - Haskett, Danielle
AU - Jensen, Rikke Krüger
AU - Marchand, Andrée Anne
AU - Tomkins-Lane, Christy
AU - O'Shaughnessy, Julie
AU - Passmore, Steven
AU - Schneider, Michael J.
AU - Shipka, Peter
AU - Stewart, Gregory
AU - Stuber, Kent
AU - Yee, Albert
AU - Ornelas, Joseph
N1 - Funding Information:
We thank the following people for their contributions to this project: Dr. Brian Gleberzon, DC, OCA observe; Heather Owens, Research Manager, and Siobhan Milner, research assistant; Dr. Clint Daniels; Dr. Shireesh Bhalerao, quality assessment; Rhona McGlasson (Bone & Joint Canada); Jill Boruff, health sciences librarian, McGill University, librarian Anne Taylor-Vaisey, health sciences librarian, UOIT; Drs. Hainan Yu, Leslie Verville, Jessica Wong, Heather Shearer, Gaelan Connell for screening and quality assessment for the updated search, CCGI staff for assistance in producing the companion document intended for patients with LSS causing NC; members of the guideline panel who served on the Delphi consensus panel including Dr. Martin Descarreaux for his valuable contribution, and members of the external review committee (Appendix 9), who made this project possible by donating their expertise and clinical judgment. Disclosures: Funding for this guideline was provided by the Canadian Chiropractic Research Foundation. The views of the funding body have not influenced the content of the guideline. A conflict of interest disclosure or declaration form was completed by all participants involved in this guideline. Three conflicts of interest were reported for this study (J.C. is the developer of the Cox Flexion-Distraction table used to treat conditions of the lumbar spine; C.A. and M.J.S. published RCTs on the treatment of LSS); these panel members abstained from voting on related recommendations.
Funding Information:
Disclosures: Funding for this guideline was provided by the Canadian Chiropractic Research Foundation. The views of the funding body have not influenced the content of the guideline. A conflict of interest disclosure or declaration form was completed by all participants involved in this guideline. Three conflicts of interest were reported for this study (J.C. is the developer of the Cox Flexion-Distraction table used to treat conditions of the lumbar spine; C.A. and M.J.S. published RCTs on the treatment of LSS); these panel members abstained from voting on related recommendations.
Publisher Copyright:
© 2021 The Authors
PY - 2021/9
Y1 - 2021/9
N2 - Lumbar spinal stenosis (LSS) causing neurogenic claudication (NC) is increasingly common with an aging population and can be associated with significant symptoms and functional limitations. We developed this guideline to present the evidence and provide clinical recommendations on nonsurgical management of patients with LSS causing NC. Using the GRADE approach, a multidisciplinary guidelines panel based recommendations on evidence from a systematic review of randomized controlled trials and systematic reviews published through June 2019, or expert consensus. The literature monitored up to October 2020. Clinical outcomes evaluated included pain, disability, quality of life, and walking capacity. The target audience for this guideline includes all clinicians, and the target patient population includes adults with LSS (congenital and/or acquired, lateral recess or central canal, with or without low back pain, with or without spondylolisthesis) causing NC. The guidelines panel developed 6 recommendations based on randomized controlled trials and 5 others based on professional consensus, summarized in 3 overarching recommendations: (Grade: statements are all conditional/weak recommendations) Recommendation 1. For patients with LSS causing NC, clinicians and patients may initially select multimodal care nonpharmacological therapies with education, advice and lifestyle changes, behavioral change techniques in conjunction with home exercise, manual therapy, and/or rehabilitation (moderate-quality evidence), traditional acupuncture on a trial basis (very low-quality evidence), and postoperative rehabilitation (supervised program of exercises and/or educational materials encouraging activity) with cognitive-behavioral therapy 12 weeks postsurgery (low-quality evidence). Recommendation 2. In patients LSS causing NC, clinicians and patients may consider a trial of serotonin–norepinephrine reuptake inhibitors or tricyclic antidepressants. (very low-quality evidence). Recommendation 3. For patients LSS causing NC, we recommend against the use of the following pharmacological therapies: nonsteroidal anti-inflammatory drugs, methylcobalamin, calcitonin, paracetamol, opioids, muscle relaxants, pregabalin (consensus-based), gabapentin (very low-quality), and epidural steroidal injections (high-quality evidence). Perspective: This guideline, on the basis of a systematic review of the evidence on the nonsurgical management of lumbar spine stenosis, provides recommendations developed by a multidisciplinary expert panel. Safe and effective non-surgical management of lumbar spine stenosis should be on the basis of a plan of care tailored to the individual and the type of treatment involved, and multimodal care is recommended in most situations.
AB - Lumbar spinal stenosis (LSS) causing neurogenic claudication (NC) is increasingly common with an aging population and can be associated with significant symptoms and functional limitations. We developed this guideline to present the evidence and provide clinical recommendations on nonsurgical management of patients with LSS causing NC. Using the GRADE approach, a multidisciplinary guidelines panel based recommendations on evidence from a systematic review of randomized controlled trials and systematic reviews published through June 2019, or expert consensus. The literature monitored up to October 2020. Clinical outcomes evaluated included pain, disability, quality of life, and walking capacity. The target audience for this guideline includes all clinicians, and the target patient population includes adults with LSS (congenital and/or acquired, lateral recess or central canal, with or without low back pain, with or without spondylolisthesis) causing NC. The guidelines panel developed 6 recommendations based on randomized controlled trials and 5 others based on professional consensus, summarized in 3 overarching recommendations: (Grade: statements are all conditional/weak recommendations) Recommendation 1. For patients with LSS causing NC, clinicians and patients may initially select multimodal care nonpharmacological therapies with education, advice and lifestyle changes, behavioral change techniques in conjunction with home exercise, manual therapy, and/or rehabilitation (moderate-quality evidence), traditional acupuncture on a trial basis (very low-quality evidence), and postoperative rehabilitation (supervised program of exercises and/or educational materials encouraging activity) with cognitive-behavioral therapy 12 weeks postsurgery (low-quality evidence). Recommendation 2. In patients LSS causing NC, clinicians and patients may consider a trial of serotonin–norepinephrine reuptake inhibitors or tricyclic antidepressants. (very low-quality evidence). Recommendation 3. For patients LSS causing NC, we recommend against the use of the following pharmacological therapies: nonsteroidal anti-inflammatory drugs, methylcobalamin, calcitonin, paracetamol, opioids, muscle relaxants, pregabalin (consensus-based), gabapentin (very low-quality), and epidural steroidal injections (high-quality evidence). Perspective: This guideline, on the basis of a systematic review of the evidence on the nonsurgical management of lumbar spine stenosis, provides recommendations developed by a multidisciplinary expert panel. Safe and effective non-surgical management of lumbar spine stenosis should be on the basis of a plan of care tailored to the individual and the type of treatment involved, and multimodal care is recommended in most situations.
KW - disease management
KW - lumbar spine stenosis
KW - neurogenic claudication
KW - nonsurgical treatment, rehabilitation
KW - Practice guideline
UR - http://www.scopus.com/inward/record.url?scp=85107658284&partnerID=8YFLogxK
U2 - 10.1016/j.jpain.2021.03.147
DO - 10.1016/j.jpain.2021.03.147
M3 - Journal article
C2 - 33857615
AN - SCOPUS:85107658284
SN - 1526-5900
VL - 22
SP - 1015
EP - 1039
JO - Journal of Pain
JF - Journal of Pain
IS - 9
ER -